Nantong Jinghua Pharmaceutical Co Ltd Financial Flexibility Index
Nantong Jinghua Pharmaceutical Co Ltd financial flexibility index. Nantong Jinghua Pharmaceutical Co Ltd (002349) has a Financial Flexibility Index of 0.26x as of September 2025. Free cash flow of CN¥102.55 Million (operating CF CN¥97.93 Million minus capex CN¥4.62 Million) represents 0% of total liabilities (CN¥393.50 Million). See cash generation quality of Nantong Jinghua Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)
Financial flexibility index of Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2025. Historical Financial Flexibility Index trend for Nantong Jinghua Pharmaceutical Co Ltd across 20 annual periods. Check Nantong Jinghua Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Nantong Jinghua Pharmaceutical Co Ltd Financial Flexibility Index by Year (2006–2025)
Nantong Jinghua Pharmaceutical Co Ltd financial flexibility index by year from 2006 to 2025. Year-by-year free cash flow to debt coverage for Nantong Jinghua Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Nantong Jinghua Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.86x | CN¥361.19 Million | CN¥340.87 Million | CN¥421.13 Million | ▼ -13.6% |
| 2024 | 0.99x | CN¥341.94 Million | CN¥311.02 Million | CN¥344.66 Million | ▲ +18.2% |
| 2023 | 0.84x | CN¥319.69 Million | CN¥291.31 Million | CN¥380.75 Million | ▼ -16.4% |
| 2022 | 1.00x | CN¥419.98 Million | CN¥358.39 Million | CN¥417.93 Million | ▲ +63.6% |
| 2021 | 0.61x | CN¥386.12 Million | CN¥305.57 Million | CN¥628.54 Million | ▼ -8.0% |
| 2020 | 0.67x | CN¥446.68 Million | CN¥328.22 Million | CN¥669.29 Million | ▼ -2.0% |
| 2019 | 0.68x | CN¥540.73 Million | CN¥285.38 Million | CN¥793.62 Million | ▲ +97.2% |
| 2018 | 0.35x | CN¥243.68 Million | CN¥83.43 Million | CN¥705.27 Million | ▼ -60.3% |
| 2017 | 0.87x | CN¥517.10 Million | CN¥75.92 Million | CN¥594.47 Million | ▼ -66.3% |
| 2016 | 2.58x | CN¥588.90 Million | CN¥343.80 Million | CN¥227.87 Million | ▲ +4193.1% |
| 2015 | -0.06x | CN¥-17.19 Million | CN¥-76.01 Million | CN¥272.27 Million | ▼ -129.8% |
| 2014 | 0.21x | CN¥74.54 Million | CN¥45.70 Million | CN¥351.96 Million | ▲ +2499.7% |
| 2013 | 0.01x | CN¥2.68 Million | CN¥-54.94 Million | CN¥328.99 Million | ▼ -99.3% |
| 2012 | 1.10x | CN¥267.51 Million | CN¥77.25 Million | CN¥242.84 Million | ▲ +11.6% |
| 2011 | 0.99x | CN¥142.33 Million | CN¥41.45 Million | CN¥144.23 Million | ▼ -14.1% |
| 2010 | 1.15x | CN¥76.95 Million | CN¥41.06 Million | CN¥66.96 Million | ▲ +53.9% |
| 2009 | 0.75x | CN¥62.16 Million | CN¥57.76 Million | CN¥83.26 Million | ▲ +196.1% |
| 2008 | 0.25x | CN¥19.49 Million | CN¥17.13 Million | CN¥77.29 Million | ▼ -28.7% |
| 2007 | 0.35x | CN¥38.31 Million | CN¥33.86 Million | CN¥108.25 Million | ▲ +80.5% |
| 2006 | 0.20x | CN¥25.13 Million | CN¥22.18 Million | CN¥128.18 Million | — |